scholarly article | Q13442814 |
P2093 | author name string | Rafael Cantón | |
Fernando Baquero | |||
Val F Lanza | |||
Teresa M Coque | |||
P2860 | cites work | Global health 2035: a world converging within a generation | Q21034164 |
The role of reticulate evolution in creating innovation and complexity | Q21296637 | ||
Natural Selection on Color Patterns in Poecilia reticulata | Q22305743 | ||
Evolution in health and medicine Sackler colloquium: Making evolutionary biology a basic science for medicine | Q24620726 | ||
Public health microbiology, a challenge for Europe | Q94946670 | ||
Developing and evaluating complex interventions: the new Medical Research Council guidance | Q24647443 | ||
The application of ecological theory toward an understanding of the human microbiome | Q26825590 | ||
Review of institute of medicine and national research council recommendations for one health initiative | Q26853206 | ||
Effects of genotypic and phenotypic variation on establishment are important for conservation, invasion, and infection biology | Q26861246 | ||
Big data: the next frontier for innovation in therapeutics and healthcare | Q27027248 | ||
The first steps of adaptation of Escherichia coli to the gut are dominated by soft sweeps | Q28235419 | ||
The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA | Q28297640 | ||
Evolutionary trajectories of beta-lactamase CTX-M-1 cluster enzymes: predicting antibiotic resistance | Q28472615 | ||
Intraspecies variation in the emergence of hyperinfectious bacterial strains in nature | Q28482256 | ||
Interaction-based evolution: how natural selection and nonrandom mutation work together | Q28652237 | ||
Evolutionary biology for the 21st century | Q28710050 | ||
Evolutionary medicine: its scope, interest and potential | Q28715053 | ||
HGT turbulence: Confounding phylogenetic influence of duplicative horizontal transfer and differential gene conversion | Q28730339 | ||
Antibiotic resistance gene abundances correlate with metal and geochemical conditions in archived Scottish soils | Q28742957 | ||
Evolution and medicine: the long reach of "Dr. Darwin" | Q28762889 | ||
The concept of allostasis in biology and biomedicine | Q29029448 | ||
An ecological and evolutionary perspective on human-microbe mutualism and disease | Q29614265 | ||
The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing | Q29615054 | ||
On the rapidity of antibiotic resistance evolution facilitated by a concentration gradient. | Q30519515 | ||
Transgressive Hybrids as Hopeful Monsters | Q30628476 | ||
Microevolutionary events involving narrow host plasmids influences local fixation of vancomycin-resistance in Enterococcus populations | Q31114643 | ||
Fecal microbiota transplantation: effectiveness, complexities, and lingering concerns | Q31147407 | ||
Cheating on the edge | Q33354150 | ||
Selection and characterization of a candidate therapeutic bacteriophage that lyses the Escherichia coli O104:H4 strain from the 2011 outbreak in Germany | Q33405088 | ||
Mobile antibiotic resistance encoding elements promote their own diversity | Q33519503 | ||
Evidence of increasing antibiotic resistance gene abundances in archived soils since 1940. | Q33520054 | ||
Symptomatic treatment (ibuprofen) or antibiotics (ciprofloxacin) for uncomplicated urinary tract infection?--results of a randomized controlled pilot trial | Q33588033 | ||
The need to look at antibiotic resistance from a health systems perspective | Q33667503 | ||
Bacterial vaccines and antibiotic resistance | Q33667565 | ||
Emergence and spread of antibiotic resistance: setting a parameter space. | Q33667581 | ||
Towards a global antibiotic resistance surveillance system: a primer for a roadmap | Q33667596 | ||
Exploring the collaboration between antibiotics and the immune response in the treatment of acute, self-limiting infections | Q33767602 | ||
Epidemic Klebsiella pneumoniae ST258 is a hybrid strain | Q33815077 | ||
Neutral microepidemic evolution of bacterial pathogens | Q33836453 | ||
Horizontal gene transfer and the origin of species: lessons from bacteria. | Q33856631 | ||
Oral DAV131, a charcoal-based adsorbent, inhibits intestinal colonization by β-lactam-resistant Klebsiella pneumoniae in cefotaxime-treated mice | Q37263410 | ||
Ibuprofen therapy for cystic fibrosis lung disease: revisited | Q37277641 | ||
The new treatment paradigm and the role of carbapenems | Q37291634 | ||
Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens | Q37302434 | ||
Inhibition of aac(6')-Ib-mediated amikacin resistance by nuclease-resistant external guide sequences in bacteria | Q37304179 | ||
Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial | Q37491940 | ||
Evolution of microbial markets | Q37543691 | ||
Antimicrobial stewardship in long term care facilities: what is effective? | Q37597198 | ||
Complex multiple antibiotic and mercury resistance region derived from the r-det of NR1 (R100). | Q37598760 | ||
Low-dose recombinant properdin provides substantial protection against Streptococcus pneumoniae and Neisseria meningitidis infection. | Q37701996 | ||
Antimicrobial drug resistance | Q37702907 | ||
Global dissemination of a multidrug resistant Escherichia coli clone | Q37711903 | ||
Gene flow, mobile genetic elements and the recruitment of antibiotic resistance genes into Gram-negative pathogens | Q37868656 | ||
Analysis of antibiotic resistance regions in Gram-negative bacteria | Q37874671 | ||
Ecology and evolution as targets: the need for novel eco-evo drugs and strategies to fight antibiotic resistance | Q37876027 | ||
Origins of bacterial diversity through horizontal genetic transfer and adaptation to new ecological niches | Q37895335 | ||
Combinatorial events of insertion sequences and ICE in Gram-negative bacteria | Q37897646 | ||
Are humans increasing bacterial evolvability? | Q37998201 | ||
Evolution of virulence in opportunistic pathogens: generalism, plasticity, and control | Q38008037 | ||
Quantitative human health risk assessments of antimicrobial use in animals and selection of resistance: a review of publicly available reports | Q38030962 | ||
Bacterial pathogens: from natural ecosystems to human hosts | Q38031603 | ||
Ecology of zoonoses: natural and unnatural histories | Q38064123 | ||
The role of the natural environment in the emergence of antibiotic resistance in gram-negative bacteria | Q38076545 | ||
Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis | Q38076970 | ||
Urban wastewater treatment plants as hotspots for antibiotic resistant bacteria and genes spread into the environment: a review. | Q38080393 | ||
Potential impact of environmental bacteriophages in spreading antibiotic resistance genes | Q38108837 | ||
Histatins: salivary peptides with copper(II)- and zinc(II)-binding motifs: perspectives for biomedical applications | Q38161949 | ||
Metagenomic insights into the human gut resistome and the forces that shape it. | Q38182909 | ||
The risk/benefit of predicting a post-antibiotic era: is the alarm working? | Q38205036 | ||
The role of behavior change in antimicrobial stewardship. | Q38214345 | ||
New Delhi Metallo-beta-lactamase around the world: an eReview using Google Maps | Q38215681 | ||
Counteracting antibiotic resistance: breaking barriers among antibacterial strategies | Q38216443 | ||
Low or high doses of cefquinome targeting low or high bacterial inocula cure Klebsiella pneumoniae lung infections but differentially impact the levels of antibiotic resistance in fecal flora | Q38324219 | ||
Escherichia coli pathotypes occupy distinct niches in the mouse intestine | Q38852242 | ||
Bacteriophage selection against a plasmid-encoded sex apparatus leads to the loss of antibiotic-resistance plasmids | Q38981951 | ||
RecA-Mediated gene conversion and aminoglycoside resistance in strains heterozygous for rRNA. | Q39470161 | ||
Systematic review of measurement and adjustment for colonization pressure in studies of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and clostridium difficile acquisition | Q36059951 | ||
Gene conversion and concerted evolution in bacterial genomes. | Q36088664 | ||
The role of clonal interference in the evolutionary dynamics of plasmid-host adaptation | Q36099779 | ||
Multidrug therapy and evolution of antibiotic resistance: when order matters | Q36156421 | ||
Evolutionary paths to antibiotic resistance under dynamically sustained drug selection | Q36500996 | ||
Is antibiotic cycling the answer to preventing the emergence of bacterial resistance in the intensive care unit? | Q36559384 | ||
Evolutionary consequences of antibiotic use for the resistome, mobilome and microbial pangenome | Q36576233 | ||
Transfer of multidrug-resistant bacteria between intermingled ecological niches: the interface between humans, animals and the environment | Q36586943 | ||
Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization. | Q36646662 | ||
Antibiotic resistance shaping multi-level population biology of bacteria | Q36660833 | ||
Bloody coli: a gene cocktail in Escherichia coli O104:H4. | Q36760515 | ||
Mobile elements, zoonotic pathogens and commensal bacteria: conduits for the delivery of resistance genes into humans, production animals and soil microbiota. | Q36804038 | ||
High rate of intestinal colonization with extended-spectrum-beta-lactamase-producing organisms in household contacts of infected community patients | Q36845508 | ||
Targeting virulence: a new paradigm for antimicrobial therapy | Q36914994 | ||
Country-specific antibiotic use practices impact the human gut resistome | Q36973632 | ||
Polymorphic mutation frequencies in Escherichia coli: emergence of weak mutators in clinical isolates | Q37007127 | ||
Antibiotic treatment expands the resistance reservoir and ecological network of the phage metagenome | Q37009655 | ||
Influence of humans on evolution and mobilization of environmental antibiotic resistome | Q37021032 | ||
Multidrug resistant commensal Escherichia coli in animals and its impact for public health | Q37138819 | ||
Human Health Risk Assessment (HHRA) for environmental development and transfer of antibiotic resistance. | Q37149760 | ||
Antibiotics and antibiotic resistance in water environments | Q37183790 | ||
Fight evolution with evolution: plasmid-dependent phages with a wide host range prevent the spread of antibiotic resistance | Q37187865 | ||
Bounded population sizes, fluctuating selection and the tempo and mode of coexistence | Q37240546 | ||
Frequency-dependent selection in bacterial populations | Q39471728 | ||
Evernimicin (SCH27899) inhibits a novel ribosome target site: analysis of 23S ribosomal DNA mutants. | Q39537223 | ||
The innate growth bistability and fitness landscapes of antibiotic-resistant bacteria | Q40768050 | ||
Selective compartments for resistant microorganisms in antibiotic gradients | Q40885917 | ||
Crisis in infectious diseases: time for a new paradigm? | Q41203935 | ||
Influence of recombination on development of mutational resistance to linezolid in Enterococcus faecalis JH2-2. | Q41853120 | ||
The emergence of bacterial "hopeful monsters" | Q41865750 | ||
Predictions: evolutionary trajectories and planet medicine | Q41957295 | ||
Individual variability in finger-to-finger transmission efficiency of Enterococcus faecium clones | Q41984439 | ||
Interaction between mutations and regulation of gene expression during development of de novo antibiotic resistance | Q42089215 | ||
Genetic contexts of blaNDM-1. | Q42383131 | ||
Assembling evidence for identifying reservoirs of infection | Q42550958 | ||
Reductionistic and holistic science | Q42706709 | ||
Process evaluation in complex public health intervention studies: the need for guidance | Q42741744 | ||
Complexity in biology. Exceeding the limits of reductionism and determinism using complexity theory | Q42785846 | ||
Bacteriophages as twenty-first century antibacterial tools for food and medicine | Q43031037 | ||
Invasion of E. coli biofilms by antibiotic resistance plasmids | Q43121610 | ||
Allodemics | Q43548342 | ||
Restricting the selection of antibiotic-resistant mutant bacteria: measurement and potential use of the mutant selection window | Q43896553 | ||
Impact of restriction of third generation cephalosporins on the burden of third generation cephalosporin resistant K. pneumoniae and E. coli in an ICU. | Q43962900 | ||
Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance | Q44144059 | ||
Hypermutable Staphylococcus aureus strains present at high frequency in subclinical bovine mastitis isolates are associated with the development of antibiotic resistance | Q44350722 | ||
Promoting resistance by the emission of antibiotics from hospitals and households into effluent | Q44574969 | ||
Following evolution of bacterial antibiotic resistance in real time. | Q45943930 | ||
Minor fitness costs in an experimental model of horizontal gene transfer in bacteria. | Q46930621 | ||
Antibiotic treatments and microbes in the gut. | Q46940081 | ||
Reduction in pediatric hospitalizations for varicella-related invasive group A streptococcal infections in the varicella vaccine era. | Q47266779 | ||
A paradigm shift in drug development for treatment of rare multidrug-resistant gram-negative pathogens | Q47738900 | ||
Effect of high-dose ibuprofen in patients with cystic fibrosis. | Q50594133 | ||
Ecology drives a global network of gene exchange connecting the human microbiome. | Q51171065 | ||
Temporal variation can facilitate niche evolution in harsh sink environments. | Q51189476 | ||
Source-sink dynamics shape the evolution of antibiotic resistance and its pleiotropic fitness cost. | Q51705053 | ||
Self-organization, complexity and chaos: the new biology for medicine. | Q52237930 | ||
Sources and sinks: a stochastic model of evolution in heterogeneous environments. | Q52713804 | ||
The broader context of antibiotic resistance: zinc feed supplementation of piglets increases the proportion of multi-resistant Escherichia coli in vivo. | Q52883165 | ||
Bacterial recombination promotes the evolution of multi-drug-resistance in functionally diverse populations. | Q53399821 | ||
Antibiotic resistance and the evolution of group-beneficial traits. II: a metapopulation model. | Q53856673 | ||
beta-Lactam coselection of sensitive and TEM-1 beta-lactamase-producing subpopulations in heterogeneous Escherichia coli colonies. | Q54455567 | ||
Experimental evolution of resistance to an antimicrobial peptide. | Q54949785 | ||
The microbiome as a human organ. | Q55056198 | ||
Emergence as a Construct: History and Issues | Q56069096 | ||
The re-emergence of ?emergence?: A venerable concept in search of a theory | Q56069097 | ||
Large-Scale Analysis of Plasmid Relationships through Gene-Sharing Networks | Q57672818 | ||
Experimentally induced life-history evolution in a natural population | Q57893518 | ||
Mutational Pathway Determines Whether Drug Gradients Accelerate Evolution of Drug-Resistant Cells | Q59444106 | ||
Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae | Q64130946 | ||
Potential confusion regarding the term 'resistance' in epidemiological surveys | Q79923646 | ||
SOME ASPECTS OF EVOLUTION | Q81119764 | ||
Evolutionary dynamics of the most populated genotype on rugged fitness landscapes | Q81425151 | ||
Emergence of antibiotic resistance: need for a new paradigm | Q84388304 | ||
Hypermutability and compensatory adaptation in antibiotic-resistant bacteria | Q84562380 | ||
When are complex interventions 'complex'? When are simple interventions 'simple'? | Q84576119 | ||
Acceleration of emergence of bacterial antibiotic resistance in connected microenvironments | Q84975610 | ||
Effectiveness of anti-inflammatory treatment versus antibiotic therapy and placebo for patients with non-complicated acute bronchitis with purulent sputum. The BAAP Study protocol. | Q33938614 | ||
Effects of probiotics on acquisition and spread of multiresistant enterococci | Q33962888 | ||
Concentration-dependent selection of small phenotypic differences in TEM beta-lactamase-mediated antibiotic resistance | Q33980535 | ||
Selection of very small differences in bacterial evolution. | Q34003853 | ||
Highways of gene sharing in prokaryotes | Q34063510 | ||
Rates of mutation and host transmission for an Escherichia coli clone over 3 years | Q34064804 | ||
What is antibiotic resistance and how can we measure it? | Q34104249 | ||
Oral-derived bacterial flora defends its domain by recognizing and killing intruders--a molecular analysis using Escherichia coli as a model intestinal bacterium | Q34195537 | ||
Prokaryote genome fluidity: toward a system approach of the mobilome. | Q34238543 | ||
Microbiota-mediated colonization resistance against intestinal pathogens | Q34324937 | ||
Collateral effects of antibiotics on mammalian gut microbiomes | Q34348999 | ||
Antibiotic resistance-the need for global solutions | Q34386251 | ||
Tackling antibiotic resistance | Q34390844 | ||
Phages limit the evolution of bacterial antibiotic resistance in experimental microcosms. | Q34426663 | ||
Inhibition of cell division induced by external guide sequences (EGS Technology) targeting ftsZ | Q34460507 | ||
Nutritional basis for colonization resistance by human commensal Escherichia coli strains HS and Nissle 1917 against E. coli O157:H7 in the mouse intestine | Q34562484 | ||
Difference in [corrected] adaptive dispersal ability can promote species coexistence in fluctuating environments | Q34577090 | ||
Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine | Q34641267 | ||
Functional screening of a metagenomic library reveals operons responsible for enhanced intestinal colonization by gut commensal microbes. | Q34667454 | ||
Prebiotics, faecal transplants and microbial network units to stimulate biodiversity of the human gut microbiome | Q34675395 | ||
Directed networks reveal genomic barriers and DNA repair bypasses to lateral gene transfer among prokaryotes | Q34729654 | ||
Community acquisition of β-lactamase producing Enterobacteriaceae in neonatal gut. | Q34775030 | ||
Role of selection in the emergence of lineages and the evolution of virulence in Neisseria meningitidis | Q34836342 | ||
Interactions in the microbiome: communities of organisms and communities of genes | Q34889744 | ||
The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy | Q35092451 | ||
Clonal expansion during Staphylococcus aureus infection dynamics reveals the effect of antibiotic intervention | Q35105644 | ||
Negative feedback and transcriptional overshooting in a regulatory network for horizontal gene transfer. | Q35105754 | ||
Impacts of anthropogenic activity on the ecology of class 1 integrons and integron-associated genes in the environment | Q35135774 | ||
Antibiotics as intermicrobial signaling agents instead of weapons | Q35194014 | ||
The influence of the accessory genome on bacterial pathogen evolution | Q35304479 | ||
Recombination in IS26 and Tn2 in the evolution of multiresistance regions carrying blaCTX-M-15 on conjugative IncF plasmids from Escherichia coli. | Q35364501 | ||
Evolutionary molecular medicine | Q35560450 | ||
From pieces to patterns: evolutionary engineering in bacterial pathogens | Q35777688 | ||
Integron involvement in environmental spread of antibiotic resistance. | Q35875852 | ||
P433 | issue | 3 | |
P921 | main subject | public health | Q189603 |
evolutionary biology | Q840400 | ||
P304 | page(s) | 223-239 | |
P577 | publication date | 2014-12-11 | |
P1433 | published in | Evolutionary Applications | Q15758978 |
P1476 | title | Public health evolutionary biology of antimicrobial resistance: priorities for intervention | |
P478 | volume | 8 |
Q35737979 | A membrane computing simulator of trans-hierarchical antibiotic resistance evolution dynamics in nested ecological compartments (ARES). |
Q41711641 | Antibiotic resistance: it's bad, but why isn't it worse? |
Q47112086 | Antimicrobial resistance and universal health coverage |
Q26753831 | Application of PK/PD Modeling in Veterinary Field: Dose Optimization and Drug Resistance Prediction |
Q42353237 | Editorial: The Global Challenge Posed by the Multiresistant International Clones of Bacterial Pathogens |
Q47631000 | Environmental factors influencing the development and spread of antibiotic resistance |
Q58797053 | Evolutionary biology and the risk of scrapie disease in sheep |
Q38414823 | Fighting microbial drug resistance: a primer on the role of evolutionary biology in public health |
Q91811717 | Five rules for resistance management in the antibiotic apocalypse, a road map for integrated microbial management |
Q53371021 | Genomic sequencing of Neisseria gonorrhoeae to respond to the urgent threat of antimicrobial-resistant gonorrhea. |
Q91973359 | Genomics of Serratia marcescens Isolates Causing Outbreaks in the Same Pediatric Unit 47 Years Apart: Position in an Updated Phylogeny of the Species |
Q64110598 | Insights Into Non-coding RNAs as Novel Antimicrobial Drugs |
Q33674296 | Lateral Antimicrobial Resistance Genetic Transfer is active in the open environment |
Q36076359 | Multiple adaptive routes of Salmonella enterica Typhimurium to biocide and antibiotic exposure. |
Q47312911 | Mutual influence of secondary and key drug‐resistance mutations on catalytic properties and thermal stability of TEM‐type β‐lactamases |
Q36295546 | Resistance to antimicrobial drugs in different surface waters and wastewaters of Guadeloupe |
Q61807394 | Simulating Multilevel Dynamics of Antimicrobial Resistance in a Membrane Computing Model |
Q28067846 | Towards the just and sustainable use of antibiotics |
Q38966367 | What if there were no new antibiotics? A look at alternatives |
Q42425875 | Within-host dynamics of infection: from ecological insights to evolutionary predictions |
Search more.